SCTX · Scribe Therapeutics, Inc. · Fails to Deliver
$17.10
+0.90 (+5.56%)
At close · Nov 4
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 2, 2026
The latest filing states the doubt was alleviated.
“Substantial doubt about our ability to continue as a going concern existed as of June 30, 2026 and was alleviated as a result of the completion of our initial public offering and concurrent private placement, which resulted in aggregate net proceeds of approximately $140.7 million.”View the 10-Q filed Sep 2, 2026
Market Cap
$320.27M
Shares
18.93M
Volume · Nov 4
204.81K
Avg daily vol (3M)
375.75K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 68,034 | $23.03 | $1,566,823 |
| 2026-09-29 | 5,775 | $21.77 | $125,722 |
| 2026-09-28 | 7,090 | $21.28 | $150,875 |
| 2026-09-25 | 12,702 | $21.61 | $274,490 |
| 2026-09-24 | 1,588 | $26.53 | $42,130 |
| 2026-09-23 | 338 | $28.07 | $9,488 |
| 2026-09-22 | 364 | $28.05 | $10,210 |
| 2026-09-21 | 92,177 | $33.00 | $3,041,841 |
| 2026-09-18 | 1,432 | $32.14 | $46,024 |
| 2026-09-15 | 4,888 | $29.42 | $143,805 |
| 2026-09-14 | 3,254 | $29.74 | $96,774 |
| 2026-09-11 | 885 | $29.47 | $26,081 |
| 2026-09-10 | 249 | $29.41 | $7,323 |
| 2026-09-09 | 314 | $31.34 | $9,841 |
| 2026-09-02 | 144 | $29.00 | $4,176 |
| 2026-08-27 | 47 | $31.70 | $1,490 |
| 2026-08-24 | 2,763 | $34.13 | $94,301 |
| 2026-08-21 | 10,204 | $32.83 | $334,997 |
| 2026-08-12 | 58 | $23.44 | $1,360 |
| 2026-08-05 | 1,465 | $22.06 | $32,318 |
Showing 1–20 of 20 settlements